Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)

VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies

ATLANTA, June 08, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE: VTAK), focused on making private aviation more accessible and flexible for modern travelers, today announced that it has made a strategic investment in Volato Group, Inc. (NYSE: SOAR).

As part of the transaction, VTAK acquired approximately 2.9 million shares of SOAR and will own approximately 7.5% of the company's outstanding common stock.

This investment provides a basis to explore potential future collaboration to improve access, efficiency, and innovation across private aviation.

"This strategic investment represents an exciting opportunity for both organizations," said David Jenkins, Chief Executive Officer of Catheter Precision. "We believe this clearly aligns our interests, strengthens our position within the private aviation ecosystem, and creates opportunities to generate long-term shareholder value for both companies. As Flyte continues to scale, we remain focused on strategic relationships that enhance our AI platform and support future growth."

"This investment provides additional capital to support our strategic initiatives while introducing a highly aligned strategic shareholder,” said Matt Liotta, Chief Executive Officer of Volato Group. “We look forward to working together to create value for both shareholder bases."
The transaction supports Flyte's strategy to expand its aviation ecosystem, pursue strategic industry partnerships, and create long-term value for VTAK shareholders. Simultaneously, for SOAR shareholders, the investment provides growth capital, introduces a strategic aviation-focused shareholder, and unlocks new opportunities for collaboration across the private aviation industry.

Additional details regarding the transaction will be provided in the Company’s Current Report on Form 8-K.

Book your next Flyte with an exclusive offer from Volato: https://www.flyflyte.com/partners/vaunt

About Flyte
Flyte is a technology-enabled regional air mobility subsidiary of Catheter Precision, Inc. operating a growing fleet of Cirrus Vision Jets. Focused on short-haul markets, Flyte provides a faster and more efficient alternative to traditional private charter travel. Flight operations are conducted through Flyte’s wholly owned subsidiary, Ponderosa Air, LLC, an FAA-certified Part 135 air carrier. With active operations and ongoing fleet expansion, Flyte is building a scalable aviation platform designed to serve underserved regional markets.

Schreibe Deinen Kommentar